Skip to main content

News & Events

News & Announcements

Baltimore Sun: Stem cells tested as potential therapy for coronavirus in trial at University of Maryland medical school

Researchers at the University of Maryland School of Medicine are participating in a trial of an experimental stem cell therapy for some of the sickest COVID-19 patients who are on ventilators.

The study is one of many going on in Maryland and elsewhere that are testing existing drug therapies, as well as new ones, to treat the disease caused by the coronavirus.

This drug was developed by Mesoblast Ltd., an Australian company that develops cell therapies. It is designed for those with moderate to severe cases of severe acute respiratory distress syndrome, called ARDS. The trial will assess whether it shortens recovery time and reduces death from COVID-19.

Read the full story from the Baltimore Sun.